These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 33254580)

  • 1. Periodontal disease and targeted prevention using aMMP-8 point-of-care oral fluid analytics in the COVID-19 era.
    Räisänen IT; Umeizudike KA; Pärnänen P; Heikkilä P; Tervahartiala T; Nwhator SO; Grigoriadis A; Sakellari D; Sorsa T
    Med Hypotheses; 2020 Nov; 144():110276. PubMed ID: 33254580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic.
    Sorsa T; Sahni V; Buduneli N; Gupta S; Räisänen IT; Golub LM; Lee HM; Pätilä T; Bostanci N; Meurman J; Pärnänen P; Nwhator SO; Singla M; Gauba K
    Expert Rev Proteomics; 2021 Aug; 18(8):707-717. PubMed ID: 34468272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a noninvasive aMMP-8 point-of-care diagnostic methodology in COVID-19 patients with periodontal disease.
    Gupta S; Mohindra R; Singla M; Khera S; Kumar A; Rathnayake N; Sorsa T; Pfützner A; Räisänen IT; Soni RK; Kanta P; Jain A; Gauba K; Goyal K; Singh MP; Ghosh A; Kajal K; Mahajan V; Suri V; Bhalla A
    Clin Exp Dent Res; 2022 Aug; 8(4):988-1001. PubMed ID: 35818743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the diagnostic discrimination ability of mouthrinse and salivary aMMP-8 point-of-care testing regarding periodontal health and disease.
    Räisänen IT; Heikkinen AM; Nwhator SO; Umeizudike KA; Tervahartiala T; Sorsa T
    Diagn Microbiol Infect Dis; 2019 Dec; 95(4):114871. PubMed ID: 31473032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of active matrix metalloproteinase-8 point-of-care test for the discrimination of periodontal health status: Comparison of saliva and oral rinse samples.
    Deng K; Wei S; Xu M; Shi J; Lai H; Tonetti MS
    J Periodontal Res; 2022 Aug; 57(4):768-779. PubMed ID: 35575900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between serum and oral matrix metalloproteinase-8 levels and periodontal health status.
    Noack B; Kipping T; Tervahartiala T; Sorsa T; Hoffmann T; Lorenz K
    J Periodontal Res; 2017 Oct; 52(5):824-831. PubMed ID: 28345244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a novel point-of-care test for active matrix metalloproteinase-8: agreement between qualitative and quantitative measurements and relation to periodontal inflammation.
    Lorenz K; Keller T; Noack B; Freitag A; Netuschil L; Hoffmann T
    J Periodontal Res; 2017 Apr; 52(2):277-284. PubMed ID: 27214099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of a point-of-care aMMP-8 test in the discrimination of periodontal health and disease.
    Deng K; Pelekos G; Jin L; Tonetti MS
    J Clin Periodontol; 2021 Aug; 48(8):1051-1065. PubMed ID: 33998040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active matrix metalloproteinase-8: A potential biomarker of oral systemic link.
    Umeizudike K; Räisänen I; Gupta S; Nwhator S; Grigoriadis A; Sakellari D; Sorsa T
    Clin Exp Dent Res; 2022 Feb; 8(1):359-365. PubMed ID: 34800007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ability of Quantitative, Specific, and Sensitive Point-of-Care/Chair-Side Oral Fluid Immunotests for aMMP-8 to Detect Periodontal and Peri-Implant Diseases.
    Alassiri S; Parnanen P; Rathnayake N; Johannsen G; Heikkinen AM; Lazzara R; van der Schoor P; van der Schoor JG; Tervahartiala T; Gieselmann D; Sorsa T
    Dis Markers; 2018; 2018():1306396. PubMed ID: 30154936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-8 levels in oral samples as a biomarker for periodontitis in the Chinese population: an observational study.
    Yuan C; Liu X; Zheng S
    BMC Oral Health; 2018 Mar; 18(1):51. PubMed ID: 29587716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. aMMP-8 Point-of-Care/Chairside Oral Fluid Technology as a Rapid, Non-Invasive Tool for Periodontitis and Peri-Implantitis Screening in a Medical Care Setting.
    Lähteenmäki H; Umeizudike KA; Heikkinen AM; Räisänen IT; Rathnayake N; Johannsen G; Tervahartiala T; Nwhator SO; Sorsa T
    Diagnostics (Basel); 2020 Aug; 10(8):. PubMed ID: 32764436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between different protein species of oral rinse MMP-8 and patient-related factors.
    Leppilahti JM; Tervahartiala T; Kautiainen H; Räisänen I; Ahonen MM; Uitto VJ; Sorsa T; Mäntylä P
    Clin Exp Dent Res; 2023 Dec; 9(6):1021-1033. PubMed ID: 37877535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active Matrix Metalloproteinase-8 (aMMP-8) Versus Total MMP-8 in Periodontal and Peri-Implant Disease Point-of-Care Diagnostics.
    Räisänen IT; Aji NRAS; Sakellari D; Grigoriadis A; Rantala I; Pätilä T; Heikkilä P; Gupta S; Sorsa T
    Biomedicines; 2023 Oct; 11(11):. PubMed ID: 38001886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of aMMP-8 point-of-care test in indicating periodontal treatment outcomes in stage III/IV periodontitis: A 24-week follow-up study.
    Yilmaz M; Sorsa T; Demir E; Gürsoy M; Suominen A; Tervahartiala T; Räisänen IT; Gürsoy UK
    J Periodontal Res; 2023 Apr; 58(2):325-335. PubMed ID: 36618000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active matrix metalloproteinase-8 and interleukin-6 detect periodontal degeneration caused by radiotherapy of head and neck cancer: a pilot study.
    Keskin M; Lähteenmäki H; Rathnayake N; Räisänen IT; Tervahartiala T; Pärnänen P; Şenışık AM; Karaçetin D; Yentek Balkanay A; Heikkilä P; Hagström J; Rautava J; Haglund C; Gursoy UK; Silbereisen A; Bostanci N; Sorsa T
    Expert Rev Proteomics; 2020 Oct; 17(10):777-784. PubMed ID: 33406924
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnostic accuracy of salivary active matrix metalloproteinase (aMMP)-8 point-of-care test for detecting periodontitis in adults: A systematic review and meta-analysis.
    Wei S; Lin T; Sáenz-Ravello G; Gao H; Zhang Y; Tonetti MS; Deng K
    J Clin Periodontol; 2024 Aug; 51(8):1093-1108. PubMed ID: 38763168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing of aMMP-8 point-of-care test with a modified new disease classification in Finnish adolescent cohorts.
    Heikkinen AM; Raivisto T; Räisänen I; Tervahartiala T; Bostanci N; Sorsa T
    Clin Exp Dent Res; 2022 Oct; 8(5):1142-1148. PubMed ID: 35676762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of chairside salivary aMMP-8 findings with periodontal parameters, potentially periodontal pathogenic bacteria and selected blood parameters in systemically healthy adults.
    Schmalz G; Hübscher AE; Angermann H; Schmidt J; Schmickler J; Legler TJ; Ziebolz D
    Diagn Microbiol Infect Dis; 2019 Oct; 95(2):179-184. PubMed ID: 31174997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical association between Periodontitis and COVID-19.
    Gupta S; Mohindra R; Singla M; Khera S; Sahni V; Kanta P; Soni RK; Kumar A; Gauba K; Goyal K; Singh MP; Ghosh A; Kajal K; Mahajan V; Bhalla A; Sorsa T; Räisänen I
    Clin Oral Investig; 2022 Feb; 26(2):1361-1374. PubMed ID: 34448073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.